新冠病毒疾病住院患者的抗凝治疗 - Suppr

Suppr

超能文献

Anticoagulation in Hospitalized Patients with Covid-19.

作者信息

Chowdhury Jehan F, Moores Lisa K, Connors Jean M

出版信息

N Engl J Med. 2020 Oct 22;383(17):1675-1678. doi: 10.1056/NEJMclde2028217.

DOI:10.1056/NEJMclde2028217

PMID:33085867

Abstract

摘要

相似文献

Anticoagulation in Hospitalized Patients with Covid-19.新冠病毒疾病住院患者的抗凝治疗

N Engl J Med. 2020 Oct 22;383(17):1675-1678. doi: 10.1056/NEJMclde2028217.

Anticoagulation in COVID-19: DDI Perspective.COVID-19中的抗凝治疗：药物相互作用视角

Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620959457. doi: 10.1177/1076029620959457.

The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.抗凝治疗对新冠病毒感染患者死亡率的影响。

Am J Cardiol. 2020 Nov 1;134:155-157. doi: 10.1016/j.amjcard.2020.08.005. Epub 2020 Aug 15.

[Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].[阿根廷COVID-19住院患者血栓预防用药建议]

Medicina (B Aires). 2020;80 Suppl 3:65-66.

Current Perspectives of Anticoagulation in Patients With COVID-19.新型冠状病毒肺炎患者抗凝治疗的现状。

J Cardiovasc Pharmacol. 2020 Aug;76(2):146-150. doi: 10.1097/FJC.0000000000000861.

Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation.接受预防性抗凝治疗的新冠肺炎住院患者的静脉血栓栓塞症

Mayo Clin Proc. 2020 Oct;95(10):2291-2293. doi: 10.1016/j.mayocp.2020.08.014. Epub 2020 Aug 13.

Lessons from the Italian COVID-19 frontline.来自意大利新冠疫情前线的经验教训。

Minerva Med. 2020 Aug;111(4):303-305. doi: 10.23736/S0026-4806.20.06664-1.

Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients.3 例住院 COVID-19 患者抗凝预防治疗并发颅内出血。

J Neurovirol. 2020 Aug;26(4):602-604. doi: 10.1007/s13365-020-00869-6. Epub 2020 Jun 22.

COVID-19 coagulopathy: an evolving story.新冠病毒感染相关凝血功能障碍：一个不断演变的故事。

Lancet Haematol. 2020 Jun;7(6):e425. doi: 10.1016/S2352-3026(20)30151-4.

Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.新型冠状病毒肺炎患者的血栓栓塞风险和抗凝治疗：新出现的证据和行动呼吁。

Br J Haematol. 2020 Jun;189(5):846-847. doi: 10.1111/bjh.16727. Epub 2020 May 4.

引用本文的文献

Heparin-induced thrombocytopenia during anticoagulation therapy for COVID-19-related pulmonary embolism: A case report.新型冠状病毒肺炎相关肺栓塞抗凝治疗期间发生肝素诱导的血小板减少症：一例报告

Medicine (Baltimore). 2024 Dec 6;103(49):e40732. doi: 10.1097/MD.0000000000040732.

Comparison of Standard Versus Intermediate Prophylaxis Dose for Venous Thromboembolism Prophylaxis in Patients Hospitalized With COVID-19 Infection.新冠病毒感染住院患者静脉血栓栓塞症预防中标准剂量与中等剂量预防用药的比较

Hosp Pharm. 2024 Feb;59(1):94-101. doi: 10.1177/00185787231194997. Epub 2023 Aug 26.

What's New in Critical Illness and Injury Science? Alteplase for severe coronavirus disease 2019: Not quite ready to clot bust just hypoxemia.危重症与创伤科学有哪些新进展？阿替普酶用于重症2019冠状病毒病：还未准备好用于溶栓，仅能改善低氧血症。

Int J Crit Illn Inj Sci. 2022 Oct-Dec;12(4):181-183. doi: 10.4103/ijciis.ijciis_82_22. Epub 2022 Dec 26.

Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way.阿哌沙班是一种口服抗凝剂，以非竞争性方式抑制严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的复制及其主要蛋白酶。

J Mol Cell Biol. 2022 Sep 21;14(6). doi: 10.1093/jmcb/mjac039.

The Role of Heparin in COVID-19: An Update after Two Years of Pandemics.肝素在新冠疫情中的作用：大流行两年后的最新情况

J Clin Med. 2022 May 30;11(11):3099. doi: 10.3390/jcm11113099.

Prediction of the need for intensive oxygen supplementation during hospitalisation among subjects with COVID-19 admitted to an academic health system in Texas: a retrospective cohort study and multivariable regression model.预测德克萨斯州学术医疗系统收治的 COVID-19 患者住院期间需要强化氧补充的需求：一项回顾性队列研究和多变量回归模型。

BMJ Open. 2022 Mar 31;12(3):e058238. doi: 10.1136/bmjopen-2021-058238.

Ischemic Stroke and Bilateral Pulmonary Embolism in COVID-19: COVID-Associated Coagulopathy or Heparin-Induced Thrombocytopenia.新型冠状病毒肺炎相关的缺血性中风和双侧肺栓塞：新冠相关凝血病还是肝素诱导的血小板减少症

J Hematol. 2022 Feb;11(1):40-44. doi: 10.14740/jh956. Epub 2022 Feb 26.

Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices.粘弹性止血检测：传统与新一代设备入门指南

J Clin Med. 2022 Feb 7;11(3):860. doi: 10.3390/jcm11030860.

The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study.老年门诊患者新冠病毒检测阳性后抗凝与不良结局的相关性：一项基于人群的队列研究。

Thromb Res. 2022 Mar;211:114-122. doi: 10.1016/j.thromres.2021.12.010. Epub 2021 Dec 13.

Dabigatran in patients with atrial fibrillation after COVID-19 hospitalization: an update of the ANIBAL protocol.新冠病毒肺炎住院后房颤患者使用达比加群：ANIBAL方案的更新

Drugs Context. 2022 Jan 24;11. doi: 10.7573/dic.2021-9-4. eCollection 2022.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验